S. Anderson (Camperdown, Australia), G. Losonczy (Budapest, Hungary)
Interleukin 18: implication in airway inflammation and pulmonary function in healthy and bronchitis type COPD smokers N. Rovina, E. Dima, C. Gerassimou, C. Gratziou, C. Roussos (Athens, Greece)
| |
Enhanced oxidative stress in the lung of klotho mouse, an aging model, as measured by the redox status of coenzyme Q9 H. Wada, K. Nishimura, M. Kashiba, S. Hagiwara, S. Mikura, K. Nakagaki, Y. Yamamoto, H. Goto (Tokyo, Tochigi, Japan)
| |
Intranasal administration of leukotriene B4 selectively increases human nasal neutrophil activity H. Widegren, M. Andersson, L. Flamand, P. Borgeat, L. Greiff (Lund, Sweden; Quebec, Canada)
| |
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation M. Bafadhel, S. Saha, R. Siva, M. McCormick, P. Rugman, P. Dodson, P. Newbold, C. E. Brightling (Leicester, United Kingdom)
| |
Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation B. Antus, I. Barta, E. Csiszer, I. Horvath (Budapest, Hungary)
| |
Airway hyperresponsiveness to mannitol and exhaled NO are related to inflammatory subtypes in asthma C. Porsbjerg, T. Kromann Lund, L. Pedersen, V. Backer (Copenhagen, Denmark)
| |
Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control J. Saito, Y. Inokoshi, K. Saito, N. Nakagawa, A. Fukuhara, T. Ishii, S. Sato, S. Oh, Y. Tanino, T. Ishida, M. Munakata (Fukushima city, Japan)
| |
Airway inflammation, airway responsiveness and treatment of asthma in elite athletes T. Lund, L. Pedersen, S. Anderson, A. Sverrild, V. Backer (Copenhagen, Denmark; Camperdown, Australia)
| |